Supplemental Annuity Collective Trust (SACT) of New Jersey’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Supplemental Annuity Collective Trust (SACT) of New Jersey’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-15,000	Closed	-$10K	–	223
2020 Q4	$10K	Hold	15,000	–	–	﹤0.01%	215
2020 Q3	$34K	Hold	15,000	–	–	0.01%	216
2020 Q2	$54K	Hold	15,000	–	–	0.02%	215
2020 Q1	$57K	Hold	15,000	–	–	0.03%	205
2019 Q4	$45K	Buy	+15,000	New	+$39K	0.02%	227

Other funds holding BMY.RT

JCI

Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return

TNB

Thomasville National Bank Thomasville, Georgia $1.82B AUM

WAM

Westport Asset Management Southport, Connecticut $245M AUM 15.03% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Supplemental Annuity Collective Trust (SACT) of New Jersey's BMY.RT Position: Q1 2021 in Review

Supplemental Annuity Collective Trust (SACT) of New Jersey sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 15,000 shares — an estimated $10K sold.

Supplemental Annuity Collective Trust (SACT) of New Jersey first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $57K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

Supplemental Annuity Collective Trust (SACT) of New Jersey reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
Supplemental Annuity Collective Trust (SACT) of New Jersey sold 15,000 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $10K.
Supplemental Annuity Collective Trust (SACT) of New Jersey first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
Supplemental Annuity Collective Trust (SACT) of New Jersey's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $57K in Q1 2020.
12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Supplemental Annuity Collective Trust (SACT) of New Jersey's 13F filing for Q1 2021, filed 26 Apr 2021.